Literature DB >> 28283473

Loss of lung WWOX expression causes neutrophilic inflammation.

Sunit Singla1, Jiwang Chen2, Shruthi Sethuraman2, Justin R Sysol2, Amulya Gampa2, Shuangping Zhao2, Roberto F Machado2.   

Abstract

The tumor suppressor WW domain-containing oxidoreductase (WWOX) exhibits regulatory interactions with an array of transcription factors and signaling molecules that are positioned at the well-known crossroads between inflammation and cancer. WWOX is also subject to downregulation by genotoxic environmental exposures, making it of potential interest to the study of lung pathobiology. Knockdown of lung WWOX expression in mice was observed to cause neutrophil influx and was accompanied by a corresponding vascular leak and inflammatory cytokine production. In cultured human alveolar epithelial cells, loss of WWOX expression resulted in increased c-Jun- and IL-8-dependent neutrophil chemotaxis toward cell monolayers. WWOX was observed to directly interact with c-Jun in these cells, and its absence resulted in increased nuclear translocation of c-Jun. Finally, inhibition of the c-Jun-activating kinase JNK abrogated the lung neutrophil influx observed during WWOX knockdown in mice. Altogether, these observations represent a novel mechanism of pulmonary neutrophil influx that is highly relevant to the pathobiology and potential treatment of a number of different lung inflammatory conditions.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  WWOX; inflammation; lung injury; neutrophils

Mesh:

Substances:

Year:  2017        PMID: 28283473      PMCID: PMC5495942          DOI: 10.1152/ajplung.00034.2017

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  73 in total

Review 1.  Smad3 signaling involved in pulmonary fibrosis and emphysema.

Authors:  Jack Gauldie; Martin Kolb; Kjetil Ask; Gail Martin; Philippe Bonniaud; David Warburton
Journal:  Proc Am Thorac Soc       Date:  2006-11

2.  Inhibition of nuclear factor-κB in the lungs prevents monocrotaline-induced pulmonary hypertension in mice.

Authors:  Li Li; Chuanyu Wei; Il-Kwon Kim; Yvonne Janssen-Heininger; Sudhiranjan Gupta
Journal:  Hypertension       Date:  2014-03-10       Impact factor: 10.190

3.  WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.

Authors:  A K Bednarek; K J Laflin; R L Daniel; Q Liao; K A Hawkins; C M Aldaz
Journal:  Cancer Res       Date:  2000-04-15       Impact factor: 12.701

4.  Cigarette Smoke Exposure and the Acute Respiratory Distress Syndrome.

Authors:  Carolyn S Calfee; Michael A Matthay; Kirsten N Kangelaris; Edward D Siew; David R Janz; Gordon R Bernard; Addison K May; Peyton Jacob; Christopher Havel; Neal L Benowitz; Lorraine B Ware
Journal:  Crit Care Med       Date:  2015-09       Impact factor: 7.598

5.  Mesenchymal cell survival in airway and interstitial pulmonary fibrosis.

Authors:  James C Bonner
Journal:  Fibrogenesis Tissue Repair       Date:  2010-08-25

6.  p53 Attenuates lipopolysaccharide-induced NF-kappaB activation and acute lung injury.

Authors:  Gang Liu; Young-Jun Park; Yuko Tsuruta; Emmanuel Lorne; Edward Abraham
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

7.  Inhibition of basal activity of c-jun-NH2-terminal kinase (JNK) represses the expression of presenilin-1 by a p53-dependent mechanism.

Authors:  Sebum Lee; Hriday K Das
Journal:  Brain Res       Date:  2008-03-28       Impact factor: 3.252

Review 8.  Cellular and molecular basis of pulmonary arterial hypertension.

Authors:  Nicholas W Morrell; Serge Adnot; Stephen L Archer; Jocelyn Dupuis; Peter Lloyd Jones; Margaret R MacLean; Ivan F McMurtry; Kurt R Stenmark; Patricia A Thistlethwaite; Norbert Weissmann; Jason X-J Yuan; E Kenneth Weir
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

9.  Inhibition of c-Jun NH2-terminal kinase or extracellular signal-regulated kinase improves lung injury.

Authors:  Hui Su Lee; Hee Jae Kim; Chang Sook Moon; Young Hae Chong; Jihee Lee Kang
Journal:  Respir Res       Date:  2004-11-27

10.  Human alveolar epithelial type II cells in primary culture.

Authors:  Pu Mao; Songling Wu; Jianchun Li; Wei Fu; Weiqun He; Xiaoqing Liu; Arthur S Slutsky; Haibo Zhang; Yimin Li
Journal:  Physiol Rep       Date:  2015-02-12
View more
  4 in total

Review 1.  Phosphorylation/de-phosphorylation in specific sites of tumor suppressor WWOX and control of distinct biological events.

Authors:  Shenq-Shyang Huang; Nan-Shan Chang
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-08

Review 2.  WWOX Loss of Function in Neurodevelopmental and Neurodegenerative Disorders.

Authors:  C Marcelo Aldaz; Tabish Hussain
Journal:  Int J Mol Sci       Date:  2020-11-24       Impact factor: 5.923

3.  Cigarette Smoke and Nicotine-Containing Electronic-Cigarette Vapor Downregulate Lung WWOX Expression, Which Is Associated with Increased Severity of Murine Acute Respiratory Distress Syndrome.

Authors:  Zhenguo Zeng; Weiguo Chen; Alexander Moshensky; Zaid Shakir; Raheel Khan; Laura E Crotty Alexander; Lorraine B Ware; C M Aldaz; Jeffrey R Jacobson; Steven M Dudek; Viswanathan Natarajan; Roberto F Machado; Sunit Singla
Journal:  Am J Respir Cell Mol Biol       Date:  2021-01       Impact factor: 6.914

Review 4.  The phenotypic spectrum of WWOX-related disorders: 20 additional cases of WOREE syndrome and review of the literature.

Authors:  Juliette Piard; Lara Hawkes; Mathieu Milh; Laurent Villard; Renato Borgatti; Romina Romaniello; Melanie Fradin; Yline Capri; Delphine Héron; Marie-Christine Nougues; Caroline Nava; Oana Tarta Arsene; Debbie Shears; John Taylor; Alistair Pagnamenta; Jenny C Taylor; Yoshimi Sogawa; Diana Johnson; Helen Firth; Pradeep Vasudevan; Gabriela Jones; Marie-Ange Nguyen-Morel; Tiffany Busa; Agathe Roubertie; Myrthe van den Born; Elise Brischoux-Boucher; Michel Koenig; Cyril Mignot; Usha Kini; Christophe Philippe
Journal:  Genet Med       Date:  2018-10-25       Impact factor: 8.822

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.